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Abstract
Activated pancreatic stellate cells (PaSC) are key participants in the stroma of pancreatic
cancer, secreting extracellular matrix proteins and inflammatory mediators. Tumors are
poorly vascularized, creating metabolic stress conditions in cancer and stromal cells that
necessitate adaptive homeostatic cellular programs. Activation of autophagy and the endo-
plasmic reticulum unfolded protein response (UPR) have been described in hepatic stellate
cells, but the role of these processes in PaSC responses to metabolic stress is unknown.
We reported that the PI3K/mTOR pathway, which AMPK can regulate through multiple
inputs, modulates PaSC activation and fibrogenic potential. Here, using primary and immor-
talized mouse PaSC, we assess the relative contributions of AMPK/mTOR signaling, autop-
hagy and the UPR to cell fate responses during metabolic stress induced by mitochondrial
dysfunction. The mitochondrial uncoupler rottlerin at low doses (0.5–2.5 μM) was added to
cells cultured in 10% FBS complete media. Mitochondria rapidly depolarized, followed by
altered mitochondrial dynamics and decreased cellular ATP levels. This mitochondrial dys-
function elicited rapid, sustained AMPK activation, mTOR pathway inhibition, and blockade
of autophagic flux. Rottlerin treatment also induced rapid, sustained PERK/CHOP UPR sig-
naling. Subsequently, high doses (>5 μM) induced loss of cell viability and cell death. Inter-
estingly, AMPK knock-down using siRNA did not prevent rottlerin-induced mTOR inhibition,
autophagy, or CHOP upregulation, suggesting that AMPK is dispensable for these
responses. Moreover, CHOP genetic deletion, but not AMPK knock-down, prevented rottle-
rin-induced apoptosis and supported cell survival, suggesting that UPR signaling is a major
modulator of cell fate in PaSC during metabolic stress. Further, short-term rottlerin treat-
ment reduced both PaSC fibrogenic potential and IL-6 mRNA expression. In contrast,
expression levels of the angiogenic factors HGF and VEGFα were unaffected, and the
immune modulator IL-4 was markedly upregulated. These data imply that metabolic stress-
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induced PaSC reprogramming differentially modulates neighboring cells in the tumor
microenvironment.
Introduction
Activated pancreatic stellate cells (PaSC) are the main cell type in the stroma of chronic pan-
creatitis and pancreatic cancer and participate in the progression of these disorders [1, 2]. After
pancreas damage [3] and in the fibrotic stroma, quiescent PaSC become “activated” and differ-
entiate into a myofibroblast phenotype that synthesizes and secretes large amounts of extracel-
lular matrix proteins, as well as various cytokines and growth factors. These factors are critical
for buildup of stroma, and exert autocrine and paracrine effects on PaSC and neighboring cells
[1, 4]. Since their identification in 1998 [5, 6], research has focused on understanding how
growth factors and cytokines, and intracellular downstream signaling govern PaSC activation.
However, little is known about the role of homeostatic cellular programs including autophagy
and endoplasmic reticulum (ER) signaling in PaSC reprogramming during activation and
under metabolically stressful conditions such as that within a poorly vascularized stromal
microenvironment.
Stellate cell activation is accompanied by rapid cell growth, proliferation, and expansion of
the mitochondria and endoplasmic reticulum (ER) networks to meet the bioenergetic and bio-
synthetic demands of the newly acquired secretory phenotype [1]. These activities are sup-
ported by a balance between PI3K/AKT/mTOR signaling and autophagy to cope with a high
demand for energy [2, 7, 8]. Autophagy is a cellular catabolic mechanism responsible for recy-
cling of organelles, proteins and lipids, thereby helping to maintain cellular homeostasis and
provide substrates for energy production. In conditions of metabolic stress, autophagy allows
cells to restore energy generation and promotes survival [9]. Autophagy is required for many
physiological processes, and its impairment is often apparent in pathologic states [10]. In a
recent study, autophagy-deficient hepatic stellate cells failed to acquire the activated state and
displayed a reduced secretory phenotype [8]. These data suggested that autophagy may modu-
late PaSC remodeling in the progression from a quiescent to an activated phenotype, and/or
favor conversion to a secretory phenotype. In this respect, recent data indicate that mTOR and
autophagy are key regulators of cellular reprogramming [11] and the hypersecretory phenotype
of senescent cells [11, 12], supporting a role for these cellular programs in PaSC
reprogramming.
Besides autophagy, the unfolded protein response (UPR) signaling is another important
homeostatic regulatory mechanism. The UPR is activated when unfolded/misfolded proteins
accumulate in the ER lumen. An adaptive UPR helps to maintain ER homeostasis by adjusting
ER protein folding and lipid synthesis demands to the bioenergetics and capacity of the ER
[13]. The UPR also modulates dynamic interactions between ER and mitochondria that sup-
port ER function. This interaction comprises several processes including ATP influx into the
ER, and regulation of mitochondrial dynamics and autophagy [14, 15]. Upon diverse cellular
stresses, the UPR can trigger proapoptotic signaling downstream of the ER-transmembrane
sensor PKR-like ER kinase (PERK). Short-term PERK activation inhibits general protein trans-
lation by catalyzing phosphorylation of eukaryotic initiation factor 2-α (eIF2α) at Ser51, while
persistent PERK activation leads to upregulation of the proapoptotic transcription factor C/
EBP homologous protein (CHOP) [16]. CHOP is required for ER stress-induced apoptosis
[17], which is promoted by diverse mechanisms including CHOP-induced transcription of
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death receptor 5 (DR5) [18], dysregulation of autophagic regulators including p62/SQSTM1
[19], and cellular ATP depletion linked to CHOP-induced increases in ER protein translation
[20].
Since ER protein folding requires high energy in the form of ATP, UPR activation can be an
indicator of low cellular energy status [21]. The integration of the UPR and autophagy with
sensors of cellular metabolism may be critical for PaSC and tumor cells to withstand and adapt
to environmental stresses such as nutrient deprivation, hypoxia and oxidative stress. AMP-acti-
vated kinases (AMPK) are key cellular energy sensors, becoming activated by conditions that
deplete cellular ATP and elevate AMP levels, such as glucose deprivation or mitochondrial
uncoupling [22]. AMPK actions promote energy production through regulation of cellular
metabolism and attenuated energy utilization to ensure cellular survival, growth and prolifera-
tion. Negative regulation of mTOR complex 1 (mTORC1) and associated anabolic processes,
along with autophagy and apoptosis induction, are hypothesized to mediate downstream
effects of AMPK [23].
Given the putative role of PaSC in neoplasia, identification of agents that differentially mod-
ulate autophagy and ER stress responses is important in developing a clinical armamentarium
to modulate PaSC or their phenotypic expression. Previously, our group showed that rottlerin,
a phytochemical from the kamala tree, caused mitochondrial stress and reduced pancreatic
tumor volume in an orthotopic model of pancreatic cancer [24, 25]. Other studies illustrated
the capacity of rottlerin to depolarize mitochondria [24, 26, 27], and showed this was accompa-
nied by activation of the metabolic sensor AMPK and disordered autophagy [28, 29]. Here, we
used cultured PaSC treated with rottlerin as a model to examine how metabolic stress caused
by mitochondrial dysfunction and ATP depletion alter autophagic and UPR signaling, cell fate,
and fibrogenic and inflammatory responses in PaSC.
Materials and Methods
Antibodies and chemicals
The following antibodies were used for Western blotting and immunofluorescence: Fibronectin
(#F3648; Sigma-Aldrich), GAPDH (#9484; Abcam), LAMP-2 (#L0668; Sigma-Aldrich),
Tom20 (FL145, #sc11415; Santa Cruz Biotechnology) and α-SMA (#A2547; Sigma-Aldrich).
Antibodies directed against phospho-p70 S6 Kinase (Thr389; #9234), p70 S6 Kinase (#2708),
phospho-S6 ribosomal protein (Ser240/244; #5364), S6 ribosomal protein (#2317), phospho-
AMPKα (Thr172; #2535), AMPKα (#2532), phospho-eIF2α (Ser51; #3597), eIF2α (#9722),
phospho-4E-BP1 (Thr37/46; #2855), CHOP (#5554; for Western blotting), CHOP (#2895; for
immunofluorescence); p44/42 MAPK (Erk1/2; #9102), Caspase-3 (#9665), Bim (#2819), LC3B
(#2775), p62/SQSTM1 (#5114), Beclin-1 (#3738), Bcl-2 (#2876), and corresponding HRP-
linked secondary antibodies were from Cell Signaling Technology.
Rottlerin (#R5648), Bafilomycin A1 (#B1793), Pepstatin A (#P5318), and E-64d (#E8640)
were from Sigma-Aldrich. MitoTracker Red CMXRos (#M-7512), 4',6-diamidino-2-phenylin-
dole (DAPI), SuperSignal™West Pico (or Femto) Chemiluminescent Substrate reagent, Pro-
Long Gold antifade mounting medium, and fluorescence-conjugated secondary antibodies
were from ThermoFisher Scientific.
Tissue digestion for PaSC isolation was performed using Pronase (#165921), Collagenase P
(#1213873) and DNase I (#10104159001), all obtained from Roche. Density gradients for PaSC
separation were prepared using Nycodenz (#AN1002423; Accurate Chemical & Scientific
Corp), Gey’s balanced salt solution (GBSS; #G9779; Sigma-Aldrich) and bovine serum albumin
fraction V (BSA; #03116956001; Roche). Cell culture DMEM/F12 medium (#11330–032) and
L-Glutamine (#25030–081) were from ThermoFisher Scientific; antibiotics/antimycotics (1%
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Penicillin-Streptomycin; #25030–081) and fetal bovine serum (FBS; #FB11) were from Omega
Scientific. All chemicals and kits were used according to the manufacturer’s recommendations,
unless otherwise indicated.
Cell culture
Primary mouse PaSC (mPaSC) were obtained from pancreas tissues from C57BL/6 wild-type
mice (Harlan), GFP-LC3 (green fluorescent protein-microtubule-associated protein 1 light
chain 3) transgenic mice [30] (C57BL/6 background; donated by Dr. Gukoskaya and Dr. Mare-
ninova), or Chop-/-mice [31] (purchased at The Jackson Laboratory and backcrossed into the
Harlan C57BL/6 background). GFP-LC3 mPaSC express GFP-LC3 fusion protein and were
used to facilitate visualization of autophagic puncta formation in live cell microscopy experi-
ments (described below). Chop-/-mPaSC were used to gain insights into the role of the tran-
scription factor CHOP in rottlerin-treated cells. Animal studies were approved by the
Institutional Animal Care and Use Committee in accordance with the NIH Guide for the Care
and Use of Laboratory Animals. The protocols were approved by the Institutional Animal Care
and Use Committee of the VA Greater Los Angeles Health Sciences Center (Protocol Number:
02009–04) and the Institutional Animal Care and Use Committee of the Cedars-Sinai Medical
Center (Protocol Number: IACUC005232).
PaSC were isolated as previously described [6] with minor modifications. Briefly, pancreata
from 1–2 mice were excised, minced and digested in GBSS containing 140 μg/ml pronase,
400 μg/ml collagenase P and 8.75 units/ml DNase I. The cell suspension was filtered through a
100 μm nylon cell strainer (Falcon, Corning) and washed in GBSS supplemented with 0.3%
BSA. Then, PaSC were separated by Nycodenz density gradient centrifugation. The Nycodenz
gradient was prepared by layering the cell suspension beneath 6 ml of 0.3% BSA/GBSS in a
polycarbonate centrifuge tube, and then centrifuged for 20 minutes at 1400 g. Quiescent PaSC
were collected from a fuzzy band at the interface near the top of the gradient, and activated and
expanded in culture up to passage 2. Activated PaSC were characterized by the presence of α-
SMA stress fibers, high production of fibronectin and reduced expression of GFAP.
Immortalized mouse PaSC (imPaSC) were obtained from Dr. Raul Urrutia [32]. Both pri-
mary mPaSC and imPaSC were grown in DMEM/F12 media supplemented with 15% FBS, 2
mM L-glutamine, and antibiotics/antimycotics, in a humidified 5% CO2 atmosphere. For
experimental purpose, cells were seeded in 60-mm dishes in complete DMEM/F12 media sup-
plemented with 10% FBS, and treated with the experimental agents while at 60–80% con-
fluency. Most of the data presented here was obtained from primary mPaSC, and additional
supporting experiments including siRNA transfection, oxygen consumption and mRNA
expression were performed in imPaSC.
MTT assay
MTT (Thiazolyl Blue Tetrazolium Bromide) assay was used to measure cellular metabolic
activity in mPaSC and imPaSC. Cells were seeded in 24-well plates at 1x104 cells per well. After
the indicated treatments in triplicates, MTT was added to the culture medium to yield a final
concentration of 0.5 mg/ml, and cells were then incubated for 3 h at 37°C in CO2 incubator.
After removing medium, DMSO was added to dissolve the insoluble formazan. Absorbance
was measured at 595 nm using a plate absorbance reader (SpectraMax M3, Molecular Devices).
ATP luminescence assay
PaSC were seeded in 60-mm dishes and treated in duplicates as indicated for 30 or 60 minutes.
After treatment, total cellular ATP levels were measured using a bioluminescence ATP
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Determination Kit (#A22066, ThermoFisher Scientific) according to the manufacturer’s
recommendations.
Oxygen consumption assay
The rates of mitochondrial oxygen consumption (OCR) in live imPaSC were measured using a
Clark-type oxygen electrode (Strathkelvin Instruments) in a closed-cell respirometric design
[33]. Briefly, cells grown in complete DMEM/F12 media supplemented with 15% FBS were
trypsinized and re-suspended in phosphate-buffered saline (PBS). After the basal respiration
rate was recorded, vehicle or rottlerin was added to the cells, data were collected for a further
15 min and the change in OCR was calculated from the raw OCR data as described [33].
DNA fragmentation assay
PaSC were plated in 60-mm dishes and treated with different concentrations of rottlerin. Apo-
ptosis was estimated by measuring internucleosomal DNA fragmentation in media and cell
lysates using Cell Death Detection ELISAPLUS kit (#11774425001, Sigma-Aldrich) according
to the manufacturer’s recommendation.
Immunoblotting
For immunoblotting experiments, cells were seeded in 60-mm culture dishes and grown in
complete 15% FBS media. At 60–80% confluency, culture media was replaced with fresh 10%
FBS media and 2 h later cells were treated as indicated. Following treatments, cells were har-
vested and lysed in RIPA buffer (20 mM Tris-HCl (pH 7.4), 1% Triton X-100, 1% sodium
deoxycholate and 0.1% SDS) supplemented with protease and phosphatase inhibitors (cOm-
pleteTM ULTRA and PhosSTOPTM, Roche). Equal amount of proteins were loaded onto
Novex1 4–20% Tris-Glycine Gels (Life Technologies), and proteins were electrophoretically
transferred onto nitrocellulose membranes using Trans-Blot1 TurboTM Transfer Pack and
Trans-Blot1 TurboTM Transfer System (Bio-Rad). Membranes were incubated with primary
and secondary antibodies, and then proteins were detected with chemiluminescence reagents
using PXi Touch Imaging System (Syngene).
Live cell microscopy
Live control- or rottlerin treated GFP-LC3 mPaSC grown on fluorodish culture dishes (World
Precision Instrument) were imaged with an inverted Nikon Eclipse TE2000-S fluorescence
microscope equipped with a CoolSnap camera (Roper Scientific). For quantification of
GFP-LC3 puncta, cells displaying>10 brightly fluorescent GFP-LC3 puncta were counted as
positive. For assessment of mitochondria membrane potential, treated GFP-LC3 cells were
loaded with MitoTracker Red CMXRos and imaged as indicated above. Images were analyzed
using the MetaMorph imaging system (Universal Imaging Corporation).
Immunofluorescence analysis
PaSC were grown on glass coverslips until reaching 60% confluency and treated as above. After
treatment, cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-
100 in PBS. After blocking with PBS containing 1% BSA and 0.01% Tween 20, immunostaining
was performed by overnight incubation with the appropriate primary antibodies. The cells
were then stained with Alexa Fluor 488 or Alexa Fluor 594 conjugated secondary antibodies
(Molecular Probes) and 4’6’-diamidino-2-phenylindole (DAPI) as nuclear counterstain.
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Images were captured using an inverted Nikon Eclipse TE2000-S fluorescence microscope and
analyzed using the MetaMorph imaging system (Universal Imaging Corporation).
siRNA transfections
imPaSC were seeded in 60-mm dishes and cultured overnight in DMEM/F12 media supple-
mented with 10% FBS. Cells were subsequently transfected with appropriate siRNAs mixed
with Lipofectamine1 3000 Transfection Reagent (Life Technologies) according to the manu-
facturer’s recommendations. Cells were treated with the experimental agents at 48 h post-
transfection. The following siRNA products obtained from GE Healthcare/Dharmacon were
used: non-targeting Pool control siRNA (#D-001810), AMPKα1 siRNA (#L-041035),
AMPKα2 siRNA (#L-040809).
Real-time PCR analysis
For mRNA expression analysis, cells were collected in buffer RLT (Qiagen) and RNA extracted
using the RNeasy1 Plus Mini Kit (#74034; Qiagen). Reverse transcription was performed with
the iScript Reverse Transcription Supermix (#170–8840; Bio-Rad) using 1 μg of total RNA, and
the synthesized cDNA samples were used as templates for quantitative real-time PCR (qPCR)
analysis. Kits were used according to the manufacturer’s instructions. All reactions were per-
formed using the Bio-Rad CFX ConnectTM Real-Time PCR Detection System and the amplifi-
cations were done with the iTaq™ Universal SYBR1 Green Supermix (Bio-Rad). The following
gene-specific oligonucleotide primers were used: p62 forward, 5’-AGCTGCCCTCAGCCCT
CTA-3’, and reverse, 5’-GGCTTCTCTTCCCTCCATGTT-3’; Dr5 forward, 5’-TGCAGAGA
GGGTATTGACTA-3’, and reverse, 5’-ACACACCGTATTTGTGGTTA-3’; Col1a1 forward,
5’-TAGGCCATTGTGTATGCAGC-3’, and reverse, 5’-ACATGTTCAGCTTTGTGGACC-3’;
Hgf forward, 5’- CTTTTTGCCTTCGAGCTATC-3’, and reverse, 5’- GGTCATGCATTCAA
CTTCTG-3’; Vegfα forward, 5’- GACTATTCAGCGGACTCAC-3’, and reverse, 5’- GCACGA
TTTAAGAGGGGAAT-3’; Il-6 forward, 5’-CGTGGAAATGAGAAAAGAGTTGTG-3’, and
reverse, 5’-CCAGTTTGGTAGCATCCATCATTTCT-3’; Il-4 forward, 5’-AGCTATTGA
TGGGTCTCAAC-3’, and reverse, 5’-CTGTGACCTCGTTCAAAATG-3’; m18s forward, 5'-A
GTCCCTGCCCTTTGTACACA-3', and reverse, 5'-CGATCCGAGGGCCTCACTA-3'. Rela-
tive transcript levels were calculated using the comparative 2-ΔΔCt method [34] and normalized
to the housekeeping gene, 18S rRNA.
Statistical analyses
All experiments were performed in triplicate unless otherwise stated. Data are presented as
mean ± SEM. Data were subjected to two tailed Student t-test for comparison between 2 groups
and two way analysis of variance (ANOVA) followed by post-hoc Tukey tests for comparisons
between more than two groups. P values<0.05 were considered significant.
Results
Studies using hepatic stellate cells indicate that autophagy and ER stress signaling modulate dif-
ferentiation from the quiescent to the activated phenotype [8, 35]. Like hepatic stellate cells,
pancreatic stellate cells (PaSC) undergo major metabolic changes upon activation, and likely
rely on autophagy and the ER unfolded protein response (UPR) to meet the bioenergetic and
biosynthetic demands of their acquired secretory phenotype and rapid proliferation. How
these cellular homeostatic processes regulate the phenotype of activated PaSC has not been
investigated. We hypothesize that activated PaSC in the microenvironment of pancreatic solid
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tumors experience metabolic stress. In this context, homeostatic cellular programs including
autophagy and ER stress signaling modulate the stellate cell activated phenotype, pro- or anti-
neoplastic responses and, ultimately cell fate.
In this study we sought to gain insight into the contribution of homeostasis dysregulation in
cultured activated mouse PaSC to cell fate decisions and fibrotic and inflammatory responses.
To modulate cellular energy status, we treated mouse PaSC grown in 10% FBS media with the
mitochondrial uncoupler, rottlerin. We and others previously showed that rottlerin, at concen-
trations ranging from 2.5 to 10 μM leads to rapid mitochondrial membrane depolarization in
pancreatic cancer cells [24] and other cell types [27]. Separate studies indicate that rottlerin
also induces autophagy and activates the UPR in other cancer cell types [26, 36].
Rottlerin reduces cellular metabolic activity in a dose-dependent manner
in PaSC
In initial studies, we determined optimal experimental conditions for induction of metabolic
stress without causing premature cell death in PaSC. Primary mPaSC cultured in 10% FBS con-
taining media were treated for 72 h with different concentrations of rottlerin, and then cellular
metabolic activity was determined by MTT assay. As illustrated in Fig 1A, 0.1 μM rottlerin had
little effect, but 72 h treatments with 0.5, 1, 2.5, 5 or 10 μM rottlerin reduced metabolic activity
Fig 1. Rottlerin affects cellular metabolic state and induces apoptotic cell death.Mouse PaSC were plated in 10% FBSmedium and treated with DMSO
as control or rottlerin at different concentrations for up to 72 h. (A) Levels of cellular metabolic activity measured by MTT assay in mPaSC treated with rottlerin
for 72 h (control O.D values were set as 1). Graph represents the mean ±SEM; n = 3. (B) Apoptosis measured by internucleosomal DNA fragmentation in cell
lysates and expressed relative to controls. Graph shows mean ± SEM; n = 4. (C) Secondary necrosis measured as internucleosomal DNA fragmentation in
the conditioned media and expressed relative to controls. Graph shows mean ± SEM for 2 independent experiments. Asterisks in graphs indicate statistical
significance (t-test, * p<0.05 as compared to control). (D) mPaSC were treated with 5 or 10 μM rottlerin for 24 hours. Cellular levels of the apoptotic regulators
caspase-3 (pro-form and active cleaved-form), Bcl2, and Bim were measured byWestern blotting. α-SMA was used as a marker of PaSC activation and as
loading control; immunoblot is representative of two independent experiments.
doi:10.1371/journal.pone.0148999.g001
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by 35, 48, 46, 49 and 64%, respectively. The potential for rottlerin to induce apoptosis were
next examined at different time points.
Apoptosis as determined by internucleosomal DNA fragmentation assay was evident in PaSC
treated with 1 or 2.5 μM rottlerin only after 72 h treatment (late apoptosis; Fig 1B). Compared to
controls, 1 μM rottlerin increased apoptosis by 1.0-fold at 24 h and 1.4-fold at 48 h; and 2.5 μM
rottlerin increased apoptosis by 1.1-fold at 24 h and 1.5-fold at 48 h, but these increases did not
reach statistical significance. In contrast, rottlerin at 5 or 10 μM induced significant apoptosis
within 48 h, with increases of 2.4-fold and 4.1-fold, respectively (early apoptosis). At the 72 h
time point, we observed apoptosis at all 4 concentrations tested (1–10 μM). At 72 h, rottlerin also
induced some late necrosis as determined by the presence of internucleosomal DNA fragments
in the conditioned media (Fig 1C). However, rottlerin treatments did not induce necrosis at ear-
lier time points, as determined by the presence of DNA fragmentation in conditioned media (Fig
1C) and by the release of lactate dehydrogenase (LDH) (not shown).
Since Bcl2 and the proapoptotic BH3-only protein Bim regulate rottlerin-induced apoptosis
in other cell types [24], we measured protein expression levels of these proteins in rottlerin-
treated cells. At 5 or 10 μM rottlerin, concentrations that induced early apoptosis, we observed
increased levels of cleaved caspase-3 but only minor changes in Bcl2 or Bim protein levels (Fig
1D). As expected, we did not observe cleaved caspase-3 or changes in Bcl2 or Bim in cells
treated with 1 or 2.5 uM rottlerin for 24 or 48 h (not shown). Thus, changes in expression levels
of these anti- and proapoptotic proteins cannot account for the rottlerin-induced apoptosis
obtained in these experiments. Based on the data illustrated in Fig 1, for subsequent studies
using primary mPaSC we chose mainly rottlerin concentrations (1–2.5 μM) that do not induce
significant cell death within 48 h. Immortalized mouse PaSC (imPaSC) are slightly more resis-
tant to metabolic disturbances (data not shown). Consequently, we used rottlerin at 1–5 μM
concentrations for experiments involving imPaSC.
Rottlerin induces mitochondria dysfunction and reduces cellular ATP
levels
Rottlerin was initially identified as a protein kinase inhibitor with some specificity for the Pro-
tein Kinase C isoform delta (PKC-δ) [37]. However, later studies convincingly demonstrated
that rottlerin acts mainly as a mitochondria uncoupler with poor selectivity for PKCs [27],
although the precise molecular target(s) for its mitochondrial uncoupling effects has not been
unambiguously identified. To determine whether rottlerin at the selected concentrations
decreases mitochondrial membrane potential, and simultaneously to assess autophagy induc-
tion, we used mPaSC isolated from wild type or GFP-LC3 transgenic mice, which express
GFP-LC3 fusion protein and are widely used to monitor autophagy. GFP-LC3 mPaSC were
loaded with MitoTracker (Red CMXRos, MITO) for 10 min to visualize functional mitochon-
dria, and then live cells treated with vehicle or rottlerin were observed by fluorescence micros-
copy. As illustrated in Fig 2A, MITO-labeled active mitochondria and diffuse LC3 staining
were visualized in all vehicle-treated cells throughout the experiment. Rottlerin at 1 μM (not
shown) or 2.5 μM (Fig 2A, top panel) induced a rapid (1–3 min) dissipation of MITO fluores-
cence in all cells, consistent with loss of mitochondrial membrane potential, and this effect per-
sisted for at least 30 min. Dissipation of the MITO signal preceded the formation of
cytoplasmic LC3 puncta that appeared in most GFP-LC3 mPaSC as early as 5 min after rottle-
rin treatment (not shown), and more robustly at 30 min (Fig 2A, lower panel). In PaSC pre-
treated for 30 min with 2.5 μM rottlerin before MITO loading, MITO fluorescence was absent
in 100% of cells. Similarly, MITO fluorescence was either absent or significantly reduced in
70% of the 24-h rottlerin pretreated cells (not shown). These data show that rottlerin induces
UPR Plays a Predominant Role in Response to Mitochondrial Stress
PLOS ONE | DOI:10.1371/journal.pone.0148999 February 5, 2016 8 / 21
rapid, sustained loss of mitochondrial membrane potential in PaSC. Also, as expected for an
uncoupler of mitochondria respiration from oxidative phosphorylation, rottlerin acutely and
significantly increased the rate of oxygen consumption during real-time measurements (Fig
2B), and reduced cellular ATP levels by 50% during fixed time (30 and 60 min) incubations
(Fig 2C). These data imply that activated PaSC, even when cultured under conditions of ade-
quate nutritional support, predominantly rely on mitochondria rather than glycolysis for
maintaining ATP energy levels and ongoing energy-dependent processes.
We next assessed whether rottlerin alters mitochondrial morphology and mitochondrial
mass. Opposing processes of mitochondrial fusion and fission undergo dynamic regulation of
the structure of the cellular mitochondrial network, termed mitochondrial dynamics [38]. Cells
under normal growth conditions have elongated, interconnected mitochondria achieved by
predominant mitochondrial fusion processes. Mitochondrial inhibitors or oxidative stress
increase fission and/or reduce fusion over time, leading to punctate-structured mitochondria
and reduced energy metabolism [39]. Here, we used immunostaining for Tom20 to determine
the mitochondrial structure and dynamics in control and rottlerin-treated PaSC. Tom20 is a
receptor protein of the translocase complex of the outer mitochondrial membrane (TOM com-
plex) involved in protein import. As illustrated in Fig 2D, in control cells mitochondria
(Tom20 green staining) appeared as long, interconnected tubular, and sometimes, branched
structures residing throughout the cytoplasm. In contrast, treatment with 2.5 μM rottlerin pro-
duced rapid disruption of the mitochondrial network, and redistribution of Tom20 into
Fig 2. Rottlerin induces rapid mitochondrial dysfunction in mPaSC that precedes LC3 puncta formation. (A) mPaSC isolated from GFP-LC3
transgenic mice were labeled with 25 nMMitoTracker (MITO; red fluorescence) for 10 min and then treated without (control) or with 2.5 μM rottlerin for the
indicated times. MITO staining (red) and GFP-LC3 puncta (green fluorescence) formation in live cells were visualized using a fluorescence microscope. (B)
Rate of cellular oxygen consumption measured in live imPaSC under basal conditions and after sequential additions of DMSO and 1 μM rottlerin. Data is
expressed as fold change relative to basal. Graph shows mean ± SEM; 3 independent experiments; * p<0.05 as compared to basal (t-test). (C) mPaSC were
treated with 1 μM rottlerin for 30 or 60 minutes and total cellular ATP levels were measured in cell lysates by luminescence assay. Graph shows mean ± SEM
for 3 independent experiments; * p<0.05 as compared to control (t-test). (D) mPaSC treated with 2.5 μM rottlerin for 1 or 24 hours were double
immunostained for the mitochondrial marker Tom20 (green staining) and the stellate cell marker α-SMA (red staining); nuclei were counter-stained with DAPI
(blue staining). Images were visualized under fluorescence microscope.
doi:10.1371/journal.pone.0148999.g002
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punctate structures, i.e., events consistent with increased fission, extensive loss of mitochon-
drial membrane potential and depletion of cellular energy [40]. Moreover, after 24 h rottlerin
treatment Tom20 staining was significantly reduced and confined to the perinuclear area in
most cells (Fig 2D), suggesting a decrease in the mitochondrial mass.
Taken together, data in Fig 2 indicate that rottlerin induces mitochondria dysfunction
and compromises cellular bioenergetics in cultured PaSC, as previously reported in other cell
types.
Rottlerin promotes autophagy dysregulation in cultured PaSC
Under conditions of reduced cellular energy, autophagy promotes cell survival by providing
nutrients that can be recycled for ATP generation [9]. In addition, autophagy can protect
from cell death by eliminating damaged mitochondria and ER components containing toxic
misfolded proteins [10]. Previous reports indicated that rottlerin alters autophagy but the
precise effects on autophagic flux and regulatory proteins vary depending on the cell type
[41].
In this study, rottlerin-induced loss of mitochondrial membrane potential was rapidly fol-
lowed by accumulation of LC3 puncta in GFP-LC3 mPaSC, indicating that rottlerin pro-
motes accumulation of autophagosomes in these cells (Fig 2A). Autophagosome
accumulation occurs because of a rapid increase in autophagosome formation (autophagy
induction), a decrease in autophagic clearance of autophagosomes by lysosomes, or both. To
gain further insight into the effects of rottlerin on autophagic flux, we monitored protein lev-
els of soluble LC3-I and the autophagic vesicle-associated form, LC3-II, as well as protein lev-
els of sequestosome-1 (p62/SQSTM1 or p62). p62/SQSTM1 is a ubiquitin-binding,
multifunctional signaling/scaffold protein that serves as link between LC3-II, autophago-
somes and polyubiquitinated proteins. p62/SQSTM1-bound polyubiquitinated proteins are
incorporated into autophagosomes and degraded in autolysosomes. Since p62 gets degraded
in the process, changes in steady state levels of p62 over time have been used as an index of
autophagic degradation. [42, 43].
Wild-type mPaSC were treated for up to 48 h with non-apoptotic rottlerin concentrations
(1–2.5 μM). Western blot analysis showed marked increases in LC3-II levels and concomitant
reduction in LC3-I as early as 15 min after rottlerin treatment, and this effect persisted for at
least 48 h (Fig 3A and 3B). These data suggest conversion of LC3-I into LC3-II in rottlerin-
treated PaSC and increased autophagic flux. Moreover, we found marked LC3 puncta forma-
tion in 90% of GFP-LC3 mPaSC after 1 h and persisting until at least 24 h post rottlerin treat-
ment (Fig 3C). Of note, GFP-LC3 cells did not exhibit apoptotic nuclear morphologic changes
during the 24h-rottlerin treatment period (not shown). Different from a previous report in
cancer stem cells [44], rottlerin treatments did not alter protein levels of the autophagy regula-
tor, beclin-1. We also found slightly decreased levels of the lysosomal membrane protein
LAMP-2 (Fig 3B).
Our data showed that rottlerin markedly increased protein levels of p62/SQSTM1 (Fig 3B).
Immunofluorescence analysis for p62/SQSTM1 showed progressive development of p62/
SQSTM1 aggregates in rottlerin-treated cells, with 5%, 18% and 90% of cells displaying p62
puncta at 1 h, 3 h and 24 h treatment, respectively (Fig 3D). These data suggest that autophago-
some degradation may be impaired in these cells, thereby accounting at least in part for the
accumulation of p62/SQSTM1. However, we found that after 6 h treatment rottlerin also
increased p62/SQSTM1 mRNA levels (see below). Thus, the sum total of the rottlerin-induced
p62/SQSTM1 accumulation may reflect contributions of both a reduction in autophagic degra-
dation as well as an increase in p62 mRNA expression.
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To further assess rottlerin effects on autophagic flux, mPaSC were treated with lysosomal
inhibitors to impair lysosomal function and block the degradation of autophagosome cargo
(Fig 3E). mPaSC were pretreated with bafilomycin A1, a lysosomal vacuolar H+-ATPase (pro-
ton pump) inhibitor, to interrupt autophagosome-lysosome fusion, then with vehicle or rottle-
rin. Western blots of LC3-II in these cell lysates showed that there was no enhancement of
rottlerin-induced increases by bafilomycin A1 pretreatment (Fig 3E), suggesting that rottlerin
alone is capable of interrupting autophagic flux. In case there was residual lysosomal function
when bafilomycin A1 alone was used as an inhibitor, cells were also pretreated with a cocktail
of lysosomal inhibitors including bafilomycin A1, E-64d (a cysteine protease inhibitor) and
pepstatin A (an aspartic protease inhibitor) before rottlerin treatment. In this case again, lyso-
somal inhibitor pretreatment did not enhance the levels of rottlerin-induced LC3-II observed
above that obtained from rottlerin treatment (Fig 3F). Taken together, these data support the
concept that rottlerin, at the low concentrations tested, induces a rapid increase in autophagic
activity in PaSC (indicated by rapid conversion of LC3-I into LC3-II) that is accompanied by a
blockade in the autophagic flux. The inability of rottlerin-treated cells to complete autophagy
can be due to the depletion in cellular ATP, required for autophagy completion, or a direct
effect of rottlerin on lysosomal function. Since functional autophagy is critical for stellate cell
survival, rottlerin-induced inhibition of autophagy further compromises cellular energy status
and substrate availability for anabolic processes.
Fig 3. Rottlerin induces autophagy dysregulation in PaSC. (A and B) Cells were treated with vehicle (-) or rottlerin for up to 48 h. Cellular protein levels of
LC3-I and its LC3-phosphatidylethanolamine conjugate (LC3-II) were analyzed byWestern blotting after short (A) and long-term treatment (B). Immunoblot in
panel B also shows protein levels of the autophagy regulators p62/SQSTM1, LAMP-2, and Beclin-1. Fibronectin and α-SMA levels are shown as
representative markers of stellate cell activation and loading controls. (C) Live imaging of GFP-LC3mPaSC treated with vehicle or 2.5 μM rottlerin for up to
24 h by fluorescence microscopy. Representative pictures show diffuse cytoplasmic distribution of GFP-LC3 in control cells and GFP-LC3 puncta formation
upon treatment with rottlerin. (D) mPaSC were immunostained for p62/SQSTM1 (green staining) and DAPI was used for visualization of nuclei. Pictures
show progressive formation of p62 aggregates in mPaSC upon rottlerin treatment. (E and F) Blockade of autophagy by lysosomal inhibitors does not affect
LC3 lipidation in mPaSC. Cells were pre-incubated for 30 min with bafilomycin A1 (E) or a lysosomal inhibitor cocktail (bafilomycin A1 + pepstatin A + E-64;
panel F), and then incubated for 1 or 24 h with 1 μM rottlerin. Protein levels of LC3 and α-SMA were measured byWestern blotting as autophagy marker and
loading controls.
doi:10.1371/journal.pone.0148999.g003
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Rottlerin inhibits mTORC1 signaling in PaSC by AMPK-independent
mechanisms
AMP-activated protein kinase (AMPK) is recognized as a critical regulator of cellular energy
homeostasis [22]. Activation of AMPK by low cellular energy charge (ATP/AMP ratios) inhib-
its anabolic processes such as protein and fatty acid synthesis, activates autophagy and can
modulate apoptosis signals in energetically compromised cells. AMPK actions are mediated at
least in part by inhibition of mTORC1, and previous reports showed that rottlerin and other
mitochondrial inhibitors such as metformin exert their effects via AMPK- and mTORC1-de-
pendent mechanisms [28, 45, 46].
To determine the participation of AMPK/mTORC1 signaling in rottlerin effects, primary or
immortalized mPaSC cultured in 10% FBS containing media (17 mM glucose) were treated
with rottlerin for up to 48 h. As illustrated in the immunoblots in Fig 4A and 4B, rottlerin
induced a rapid and potent activation of AMPK, as shown by a significant increase in phos-
phorylation of AMPK α subunit at Thr172, and this effect persisted for 48 h (not shown).
Moreover, rottlerin dose-dependently inhibited mTOR signaling as indicated by reduced phos-
phorylation of the mTORC1 substrates p70 S6 kinase at Thr389, S6 at Ser240/244, and 4E-BP1
at Thr37/46 (Fig 4A and 4B). Therefore, inhibition of mTORC1 substrates is linked to reduced
cell growth and proliferation, and inhibition in protein translation.
As mentioned above, several reports showed that rottlerin exerts its effect through AMPK-
dependent mechanism. To further interrogate the role of AMPK in rottlerin-induced mTOR
Fig 4. Rottlerin inhibits mTOR activation and autophagy in PaSC by AMPK-independent mechanisms. (A) Primary mouse PaSC were treated with
1 μM rottlerin andWestern blotting analysis was used to determine the activation state of AMPK and the mTORC1 targets p70 S6K and 4E-BP1. (B and C)
Immortalized mouse PaSC were transfected with non-targeting (“con”) or AMPKα1/2 siRNA (“AMPK”) and then treated with rottlerin at the indicated
concentrations for 1 h or 24 h. (B) Levels of total and phosphorylated AMPK, p70 S6K, S6 and ERK (loading control) were measured byWestern blotting. (C)
Levels of the autophagic markers LC3, p62, and GAPDH (loading control) were measured byWestern blotting. (D) Cellular metabolic state of mock-
transfected or AMPKα1/2 siRNA transfected imPaSC treated with vehicle or rottlerin for 72 hours was assessed by MTT assay. Graph shows O.D. values
relative to control cells (mean ±SEM). As indicated in the graph, the reduction in cellular metabolic state induced by rottlerin was comparable in mock- and
siRNA transfected cells. Data is representative of 3 independent experiments; ns = no statistical significant differences between control and AMPK siRNA
transfected cells (t-test).
doi:10.1371/journal.pone.0148999.g004
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signaling inhibition, we knocked down expression of both α1 and α2 AMPK catalytic subunits
in imPaSC by transfection with specific siRNA. As shown in Fig 4B, control siRNA treated
imPaSC exhibited dramatic AMPK activation in response to rottlerin, as judged by AMPK
Thr172 phosphorylation, as well as potent inhibition of mTORC1, as determined by decreases
in the phosphorylation state of the mTORC1 substrates p70S6K at Thr389 and S6 at Ser240/
244. However, whereas siRNA mediated knockdown of AMPK dramatically attenuated the
appearance of Thr172-phosphorylated (active AMPK), this was not accompanied by any rever-
sal of the rottlerin-induced mTORC1 inhibition (Fig 4B). Moreover, siRNA treatment did not
prevent rottlerin-induced accumulation of the autophagy markers p62 and LC3 (Fig 4C) or the
decrease in cellular metabolic activity, as determined by MTT assay (Fig 4D). In conclusion,
our data indicates that, at the doses and under the conditions tested, rottlerin inhibition of
mTOR signaling and autophagy are predominantly mediated by AMPK-independent
mechanisms.
Endoplasmic reticulum stress and transcription factor CHOPmodulate
cell fate in rottlerin-treated PaSC
Metabolic stress or mitochondrial dysfunction is linked in many cells to activation of homeo-
stasis pathways including autophagy and ER stress responses. The best characterized ER stress
response is the Unfolded Protein Response (UPR), a complex signaling system that is activated
by the presence of unfolded proteins within the ER lumen. The UPR governs ER function as
well as prosurvival or proapoptotic cell fate decisions upon diverse cellular stresses. During
recent years, experimental evidence has identified intense crosstalk among the UPR, autophagy
and mitochondria [47]. Autophagy can get activated by reductions in cellular energy state and
subsequent inhibition of mTOR signaling as well as by UPR activation [48]. Moreover, evi-
dence supports an interaction between the UPR and mTOR that modulates autophagy activity
and apoptosis, although the mechanisms underlying this interaction are not well defined yet
[49].
Our studies indicate that rottlerin persistently activates signaling downstream of the UPR
sensor PERK in mPaSC. In particular, rottlerin treatment induced robust phosphorylation of
eukaryotic translation initiation factor 2 alpha (eIF2α) at Ser 51, an effect linked to general
blockade of ER protein translation (Fig 5A and 5B). Moreover, rottlerin, at concentrations as
low as 0.5 μM and more robustly at 1 and 5 μM, upregulated CHOP, a transcription factor that
modulates ER protein translation in conditions of ER stress, and promotes ER-dependent apo-
ptosis (Fig 5A and 5B). In rottlerin-treated PaSC, CHOP could be visualized by immunofluo-
rescence in the nuclei of approximately 15% of cells at 1 h (not shown), 35% of cells at 3 h, and
95% of cells at 24 h treatment (Fig 5C). As we observed for mTOR signaling, AMPK knock-
down did not prevent rottlerin effects on eIF2α phosphorylation or CHOP expression (Fig
5D), suggesting that AMPK does not regulate ER stress signaling in our experimental
conditions.
Interestingly, compared to wild type, mPaSC isolated from CHOP deficient mice (Chop -/-)
displayed comparable levels of LC3-II after rottlerin treatment, but reduced ER stress, as indi-
cated by the ER stress marker GRP78 (Fig 5E). Moreover, genetic CHOP deletion significantly
reduced apoptosis and increased cell survival in response to high concentrations of rottlerin
(Fig 5F and 5G), supporting a key role for the UPR and CHOP in regulating cell fate decisions
under metabolic stress. The mechanisms underlying CHOP proapoptotic effects are not
completely understood. Proposed mechanisms include ATP depletion by promoting ATP-
dependent ER protein translation in conditions of ER stress [20], dysregulation of autophagic
regulators including p62/SQSTM1 [19, 41], and upregulation of cell death receptor 5 (DR5)
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Fig 5. CHOP regulates cell death in rottlerin-treated PaSC. (A and B) mPaSC were treated with different
concentrations of rottlerin at the indicated times. Activation of the PERK/eIF2α branch of the UPRmeasured
by the protein levels of total and phosphorylated eIF2α and the proapoptotic transcription factor CHOP.
GAPDH expression was analyzed as a loading control. As shown, CHOP upregulation could be detected as
early as 15 min in cells treated with 1 μM rottlerin (A) and this effect was sustained for at least 24 h (B). (C)
Immunofluorescence for CHOP (red staining) in nuclei (blue DAPI staining) of mPaSC treated with 1μM
rottlerin for 3 h and 24 h. (D) AMPKα1/2 were silenced by siRNA in imPaSC and then cells treated with
rottlerin at indicated concentrations for 1 h or 24 h. p-eIF2α, total eIF2α, CHOP and GAPDH (loading control)
were measured byWestern blotting. (E) mPaSC isolated from wild type (WT) or Chop -/-mice were treated
with rottlerin for 24 h. Immunoblots show protein levels of CHOP, GRP78, LC3 and GAPDH (loading control).
(F and G) Cell death was assessed in WT or Chop -/-mPaSC treated with rottlerin for 48 h. Apoptosis was
determined by DNA fragmentation ELISA (panel F) and cell number (panel G). Data in graphs is presented as
mean ±SEM, n = 3; * p<0.05 as compared to WT; # p<0.05 as compared to control at 0 μM rottlerin (two way
ANOVA followed by post-hoc Tukey tests). (H and I) p62 (panel H) and death receptor 5 (Dr5; panel I) mRNA
levels were determined by qPCR in rottlerin-treated WT andChop -/-mPaSC. As indicated, rottlerin-induced
upregulation of p62 and Dr5 were blunted in Chop -/- cells. Data in graphs is presented as mean ±SEM,
n = 3–4; * p<0.05 as compared to WT; # p<0.05 as compared to time 0 (two way ANOVA followed by post-
hoc Tukey tests).
doi:10.1371/journal.pone.0148999.g005
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[18, 50]. In our study, we found that genetic deletion of CHOP prevented rottlerin-induced
upregulation of p62/SQSTM1 and Dr5 mRNA (Fig 5H and 5I), supporting a role for these pro-
teins in CHOP regulation of apoptosis responses in PaSC.
Metabolically stressed PaSC differentially regulate gene expression
Activated PaSC participate in the remodeling of surrounding extracellular matrix (ECM)
through deposition of collagens and other ECM components, and also exert paracrine effects
on neighboring cells by the release of mitogenic factors and inflammatory cytokines [4]. To
determine further the phenotype of metabolically stressed PaSC, we assessed by qPCR the
expression of key factors produced by these cells. For these studies, we treated immortalized or
primary mPaSC with 1, 2.5 or 5 μM rottlerin for 24 h, a time point when cells did not exhibit
loss in cell viability or apoptosis (Fig 1), but did show marked inhibition of mTOR (Fig 4B) and
activation of PERK/CHOP signaling (Fig 5B and 5D). Fig 6 illustrates the data obtained in
imPaSC; similar results were obtained in primary mPaSC (not shown).
Our data indicate that rottlerin reduces fibrogenic potential in PaSC as indicated by
decreased cellular expression of the stellate cell marker α-SMA (Fig 6A), and reduced produc-
tion of the extracellular matrix (ECM) proteins collagen type I, alpha 1 (Fig 6B), the main colla-
gen in fibrotic tissues, and fibronectin (Fig 3B). Interestingly, as shown in Fig 6C and 6D
rottlerin treatment even at 5 μM concentration did not affect expression levels of the growth
factors hepatocyte growth factor (HGF) and vascular endothelial growth factor alpha
(VEGFα). Both HGF and VEGFα have angiogenic properties in pancreatic cancer and promote
tumor growth and invasion [51, 52]. Studies in cardiomyoblasts showed that VEGFα expres-
sion was unresponsive to metabolic stress inhibition due to enhanced mRNA stability in condi-
tions of stress [53]. We have not assessed whether a similar mechanism is responsible for
preservation of HGF or VEGFαmRNA expression in rottlerin-treated PaSC, but a sustained
production of these growth factors by PaSC may support angiogenesis in the tumor microenvi-
ronment even in conditions of hypoxia and metabolic stress. We can speculate that in condi-
tions of hypovascularization, metabolically stressed PaSC would decrease the production of
ECM proteins but they would retain their capacity to support angiogenic processes that allevi-
ate hypoxia and poor substrate availability and fuel tumor progression.
Cytokines are important intercellular mediators and autocrine factors within the inflam-
matory microenvironment due to their ability to support biological responses in their target
cells. Accordingly, we also measured expression levels of IL-6, IL-4 and IL-13 generated by
PaSC. IL-6 signaling has been implicated in various cancers, as the IL-6 receptor complex is
linked to JAK activity targeting STAT3. IL-4 has roles in immune cell modulation. Different
from signaling by the IL-6 receptor, that mediated by the IL-4 receptor is mainly propagated
via STAT6. As determined by qPCR, IL-13 mRNA levels were very low in both control and
rottlerin treated cells (not shown). By contrast, IL-6 expression was robust in control cells,
although it decreased by 2-fold in rottlerin-treated cells (Fig 6E). Surprisingly, we found and
show here for the first time that expression levels of IL-4 increased by rottlerin treatment in a
dose dependent manner (Fig 6F). These data indicate that, compared with IL-6 production,
IL-4 is more readily expressed under conditions of low cellular energy. This implies in gen-
eral that cytokine production is differentially regulated in PaSC under conditions of low cel-
lular energy and ER stress, with some cytokines including IL-4 being preferentially up-
regulated. This data may have further significance, since IL-4 has been implicated in immu-
noregulation of pancreatic fibrosis via PaSC [54]. In particular, a recent study implicated
PaSC as the source of IL-4 as an essential factor inducing alternatively activated macrophages
[54].
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Discussion
Activated pancreatic stellate cells are established as the central cell type responsible for generat-
ing stroma, but the effects of metabolic perturbation that may lead to differential pro- or anti-
tumorigenic effects on these cells remain largely unexplored. To selectively impair mitochon-
drial function and assess its consequences, we selected rottlerin, a natural product with a long
history of use in traditional medicine and with some promise as an anti-tumorigenic agent [55,
56].
To selectively observe changes, rottlerin doses were titrated to levels that did not produce
significant cell death, even at extended incubations of 48 h. Previous studies showed that rottle-
rin impairs mitochondrial function in several cell types [24, 26, 27], but this effect was not pre-
viously examined in activated PaSC. Our data document convincingly that low concentrations
of rottlerin (1–2.5 μM) abolished mitochondrial membrane potential and led to dramatic
restructuring of mitochondria from a widespread, interlocked network, first to dispersed
puncta and then to a disorganized, diminished mass localized to the perinuclear region. These
data confirmed mitochondrial alterations as an early event in response to rottlerin treatment in
PaSC.
Fig 6. Metabolically stressed PaSC exhibit differential expression of profibrotic and inflammatory
markers. imPaSC were treated with rottlerin at different concentrations for 24 h. mRNA expression of (A)
αSMA, (B) Col1a1, (C) Hgf, (D) Vegfα, (E) Il-6 and (F) Il-4was determined by qPCR. Data in graph is mean
±SEM from three independent experiments; * p<0.05 as compared to WT (t-test).
doi:10.1371/journal.pone.0148999.g006
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We then examined the loss of cellular energy in PaSC and its effects on major regulatory sig-
naling pathways. ATP was depleted rapidly and AMPK was activated as shown in other studies
with rottlerin in other cell types [28, 29]. In rottlerin-treated PaSC, mTOR activity was also
diminished, and autophagy appeared to be stimulated at the level of regulatory control by
mTOR, but also blocked at the level of autolysosome resolution. This autophagic blockade and
the mTOR inactivation were not removed by siRNA-mediated knockdown of both (α and β)
isoforms of AMPK, suggesting that AMPK-independent pathways contribute to the overall
inhibition of mTOR as well as autophagy induction and downstream impairment. Consistent
with these observations, Kalender et al [57] reported that in mouse embryonic fibroblasts met-
formin, an anti-diabetic drug that decreases mitochondrial oxidative phosphorylation, inhibits
mTORC1 via Rag GTPases rather than via AMPK activation, and similar AMPK-independent
effects were reported for low concentrations of metformin in pancreatic cancer cells [46].
mTORC1, by integrating nutrient and hypoxia signaling is an important repressor of autop-
hagy and a key regulator of protein synthesis and growth. Emerging evidence also supports a
critical role for mTORC1 and autophagy in fibroblast reprogramming and plasticity [11], an
effect modulated by accumulation of p62. Our data shows that rottlerin-induced mitochondrial
impairment led to significant increase in p62 protein levels and formation of p62 protein aggre-
gates, effects linked to diminished turnover as well as an increase in steady state p62 mRNA
levels. We have not assessed whether direct rottlerin effects on mTORC1 and/or p62 modulate
metabolic reprograming in PaSC, but our data associate inactivation of mTORC1 and p62
accumulation with reduced fibrogenic potential and differential transcriptional regulation of
inflammatory cytokines, results that have important implications due to the pleiotropic effects
of PaSC in the tumor stroma. We found that rottlerin decreased expression of IL6, a potent
protumorigenic cytokine, but increased expression of IL4, an important immune modulator of
activated T cells and macrophages. Interestingly, p62 deficiency in stromal fibroblasts has been
associated with overexpression of IL6 and promotion of prostate tumorigenesis [58], support-
ing a role for p62 in regulating inflammatory responses in the tumor stroma.
In this study, we also examined ER stress pathways to determine their involvement in the
intermediate- and long-term effects of mitochondrial impairment. We found that activation of
the eIF2α-CHOP pathway was dramatically upregulated by rottlerin, and cell death in response
to rottlerin was diminished in Chop -/- PaSC. These data establish that CHOP induction is
important in the cellular fate response to mitochondrial impairment in PaSC. We also found
that rottlerin-induced p62 overexpression was blunted in Chop -/- PaSC, a result consistent
with previous reports demonstrating that CHOP can directly activate transcription of p62 and
other autophagic regulators [19]. Interestingly, Goodall et al [59] reported that CHOP differen-
tially regulates the profile of cytokines produced in dendritic cells. In particular, they found
that CHOP specifically upregulated IL23 expression in LPS-treated monocyte-derived den-
dritic cells without altering expression levels of IL8, IL1β or CCL-3. We have not assessed yet
the role of CHOP in the secretory profile of rottlerin-treated PaSC, but it is tempting to specu-
late that PERK/CHOP signaling can modulate inflammatory responses in PaSC via p62 regu-
lated pathways or via direct transcription of specific inflammatory cytokines.
In sum, our data indicate that metabolically stressed PaSC modulate pro-fibrogenic and
proinflammatory responses in a different manner than non-stressed PaSC, and imply that such
phenotypic changes affect the dynamics of pancreatic fibrosis development or tumor progres-
sion. PaSC within the microenvironment of chronic pancreatitis and pancreatic adenocarci-
noma have been reported to have pro-tumorigenic effects [4]. However, more recently the pro-
tumorigenic role of PaSC has been questioned and evidence presented for an anti-tumorigenic
properties of this cell type [60, 61]. It therefore seems that PaSC can exhibit distinct pheno-
types, perhaps in response to specific environmental changes and nutrient availability in the
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tumor microenvironment. For example, PaSC responses may vary regionally in the tumor
depending on their proximity to well vascularized areas or hypovascularized, hypoxic areas.
They can also vary temporally during tumor progression. Presumably, the profile or spectrum
of cytokines secreted by the affected cells is an important and pivotal determinant of their over-
all pro- or anti-tumorigenic roles. Effective reprogramming to a nontumorigenic phenotype
can be achieved as a therapeutic goal, only when appropriate stimuli have been identified and
characterized. Further studies are needed to resolve the full range of activities of PaSC under
different conditions and the potential for therapeutic intervention.
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